Medical cannabis in Israel: a comprehensive review of trends and regulations, 2011–2025
Abstract Background: Since its initial approval in 1992, medical cannabis (MC) in Israel has undergone extensive regulatory and structural transformation.…
Joshua Aviram
Evaluating Sex Differences in Efficacy, Safety and Pharmacokinetics in Patients Treated with Cannabis by a Metered-Dose Inhaler
Abstract Background: Clinical studies on medical cannabis (MC) treatment have shown sex-related differences, including higher susceptibility to adverse events among…
THC degradation does not impair the accuracy of THC doses aerosolized by the metered-dose SyqeAir inhaler: a 24-month stability trial
Abstract Background: Although the worldwide use of medical cannabis (MC) is on the rise, there is insufficient data regarding the…
The Effectiveness and Safety of Medical Cannabis for Treating Cancer Related Symptoms in Oncology Patients
Abstract The use of medical cannabis (MC) to treat cancer-related symptoms is rising. However, there is a lack of long-term…
Long-term effectiveness and safety of medical cannabis administered through the metered-dose Syqe Inhaler
Abstract Supplemental Digital Content is Available in the Text. Administration of low-dose medical cannabis through the metered-dose Syqe Inhaler demonstrates…
Sex differences in medical cannabis-related adverse effects
Abstract Supplemental Digital Content is Available in the Text. Women are more susceptible to medical cannabis–related adverse effects because of…
Prolonged Medical Cannabis Treatment is Associated With Quality of Life Improvement and Reduction of Analgesic Medication Consumption in Chronic Pain Patients
Abstract Introduction: Chronic non-cancer pain (CNCP) is one of the most prevalent indications for medical cannabis (MC) treatment globally. In…
Short-Term Medical Cannabis Treatment Regimens Produced Beneficial Effects among Palliative Cancer Patients
Abstract In the last decade the use of medical cannabis (MC) for palliative cancer treatment has risen. However, the choice…
Migraine Frequency Decrease Following Prolonged Medical Cannabis Treatment: A Cross-Sectional Study
Abstract Background: Medical cannabis (MC) treatment for migraine is practically emerging, although sufficient clinical data are not available for this…
Cannabinoid and Terpenoid Doses are Associated with Adult ADHD Status of Medical Cannabis Patients
Abstract Objective: The aim of this cross-sectional questionnaire-based study was to identify associations between the doses of cannabinoids and terpenes…